Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Government Regulation"" wg kryterium: Temat


Tytuł :
Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective.
Autorzy :
Kehoe T; United States Food and Drug Administration, Silver Spring, MD, 20993, USA.
Blind E; European Medicines Agency, London, E14 5EU, UK.
Janssen H; European Medicines Agency, London, E14 5EU, UK.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Jun; Vol. 85 (6), pp. 1208-1212. Date of Electronic Publication: 2018 Dec 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Government Regulation*
Bone Density Conservation Agents/*therapeutic use
Bone Diseases, Metabolic/*drug therapy
Bone Remodeling/*drug effects
Drug Approval/*legislation & jurisprudence
Drug Development/*legislation & jurisprudence
United States Food and Drug Administration/*legislation & jurisprudence
Biosimilar Pharmaceuticals/therapeutic use ; Bone Density Conservation Agents/adverse effects ; Bone Diseases, Metabolic/diagnosis ; Bone Diseases, Metabolic/physiopathology ; Drugs, Generic/therapeutic use ; Europe ; Humans ; Patient Safety ; Policy Making ; Product Surveillance, Postmarketing ; Risk Assessment ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Hospital EDs failing to care for SUDs may violate federal law: Report.
Autorzy :
Knopf, Alison
Pokaż więcej
Temat :
SUBSTANCE abuse treatment
HOSPITALS
MEDICAL quality control
HOSPITAL emergency services
PROFESSIONS
HEALTH services accessibility
GOVERNMENT regulation
DRUG overdose
MEDICAL care
PATIENTS
LEGAL liability
MEDICAL screening
LEGAL compliance
OPIOID abuse
Źródło :
Alcoholism & Drug Abuse Weekly. 7/26/2021, Vol. 33 Issue 29, p1-4. 4p.
Terminy geograficzne :
UNITED States
Periodyk
Tytuł :
Relationships between US state alcohol policies and alcohol outcomes: differences by gender and race/ethnicity.
Autorzy :
Subbaraman MS; Alcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Mulia N; Alcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Kerr WC; Alcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Patterson D; Alcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Karriker-Jaffe KJ; Alcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Greenfield TK; Alcohol Research Group, Public Health Institute, Emeryville, CA, USA.
Pokaż więcej
Źródło :
Addiction (Abingdon, England) [Addiction] 2020 Jul; Vol. 115 (7), pp. 1285-1294. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Alcohol Drinking/*epidemiology
Alcoholic Beverages/*economics
Alcoholic Beverages/*legislation & jurisprudence
Alcoholism/*epidemiology
Commerce/*legislation & jurisprudence
Taxes/*legislation & jurisprudence
Alcohol Drinking/economics ; Alcoholism/economics ; Commerce/trends ; Diagnostic and Statistical Manual of Mental Disorders ; Ethnic Groups/statistics & numerical data ; Female ; Gender Identity ; Government Regulation ; Humans ; Male ; Race Factors/statistics & numerical data ; State Government ; Taxes/trends ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Rethinking the Importance of the Individual within a Community of Data.
Autorzy :
Spector-Bagdady K
Beever J
Pokaż więcej
Źródło :
The Hastings Center report [Hastings Cent Rep] 2020 Jul; Vol. 50 (4), pp. 9-11. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
COVID-19*
Research Subjects*
Biomedical Research/*ethics
Informed Consent/*ethics
Ethics Committees, Research ; Federal Government ; Government Regulation ; Human Experimentation/ethics ; Humans ; Policy Making ; Research Design
Czasopismo naukowe
Tytuł :
The impact of parallel regulatory-health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.
Autorzy :
Tafuri G; Italian Medicines Agency (AIFA), Via del Tritone, 181-00187, Rome, Italy.
Lucas I; European Medicines Agency (EMA), 30 Churchill Place, London, E14 5EU, United Kingdom.
Estevão S; The National Health Care Institute (ZIN), 4 Eekholt, Diemen, 1112 XH, The Netherlands.
Moseley J; European Medicines Agency (EMA), 30 Churchill Place, London, E14 5EU, United Kingdom.
d'Andon A; Haute Autorité de Santé (HAS), 5 Avenue du Stade de France, 93210, Saint-Denis, France.
Bruehl H; The Federal Joint Committee (G-BA), Wegelystr. 8, D-10623, Berlin, Germany.
Gajraj E; The National Institute for Health and Care Excellence (NICE), 10 Spring Gardens, London, SW1A 2BU, United Kingdom.
Garcia S; Spanish Agency of Medicines and Medical Devices (AEMPS), Calle Campezo 1, Edificio 8, 28022, Madrid, Spain.
Hedberg N; Dental and Pharmaceutical Benefits Agency (TLV), Fleminggatan 18, 104 22, Stockholm, Sweden.
Massari M; Italian Medicines Agency (AIFA), Via del Tritone, 181-00187, Rome, Italy.
Molina A; Servei Català de la Salut (CatSalut), Travessera de les Corts, 131-159, Edifici Olímpia, 08028, Barcelona, Spain.
Obach M; Servei Català de la Salut (CatSalut), Travessera de les Corts, 131-159, Edifici Olímpia, 08028, Barcelona, Spain.
Osipenko L; The National Institute for Health and Care Excellence (NICE), 10 Spring Gardens, London, SW1A 2BU, United Kingdom.
Petavy F; European Medicines Agency (EMA), 30 Churchill Place, London, E14 5EU, United Kingdom.
Petschulies M; The Federal Joint Committee (G-BA), Wegelystr. 8, D-10623, Berlin, Germany.
Pontes C; Servei Català de la Salut (CatSalut), Travessera de les Corts, 131-159, Edifici Olímpia, 08028, Barcelona, Spain.
Russo P; Italian Medicines Agency (AIFA), Via del Tritone, 181-00187, Rome, Italy.
Schiel A; Norwegian Medicines Agency (NoMA), Strømsveien 96, 0663, Oslo, Norway.
Van de Casteele M; National Institute for Health and Disability Insurance (INAMI-RIZIV), Avenue de Tervueren 211, 1150, Bruxelles, Belgium.
Zebedin-Brandl EM; Main Association of Austrian Social Security Institutions (HVB), Kundmanngasse 21, A-1031, Vienna, Austria.
Rasi G; European Medicines Agency (EMA), 30 Churchill Place, London, E14 5EU, United Kingdom.
Vamvakas S; European Medicines Agency (EMA), 30 Churchill Place, London, E14 5EU, United Kingdom.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2018 May; Vol. 84 (5), pp. 1013-1019. Date of Electronic Publication: 2018 Mar 05.
Typ publikacji :
Journal Article
MeSH Terms :
Government Regulation*
Drug Development/*statistics & numerical data
Drug Industry/*statistics & numerical data
Technology Assessment, Biomedical/*statistics & numerical data
Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies